Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Divestments (2022 - 2025)

Bio-Techne has reported Divestments over the past 8 years, most recently at $1.4 million for Q3 2025.

  • Quarterly results put Divestments at $1.4 million for Q3 2025, down 3.71% from a year ago — trailing twelve months through Dec 2025 was $2.6 million (up 85.39% YoY), and the annual figure for FY2023 was $17.8 million, changed.
  • Divestments for Q3 2025 was $1.4 million at Bio-Techne, up from $1.2 million in the prior quarter.
  • Over the last five years, Divestments for TECH hit a ceiling of $17.8 million in Q3 2022 and a floor of $1.2 million in Q1 2025.
  • Median Divestments over the past 4 years was $1.4 million (2024), compared with a mean of $4.8 million.
  • Biggest five-year swings in Divestments: crashed 87.94% in 2023 and later fell 3.71% in 2025.
  • Bio-Techne's Divestments stood at $17.8 million in 2022, then crashed by 87.94% to $2.1 million in 2023, then crashed by 34.71% to $1.4 million in 2024, then fell by 3.71% to $1.4 million in 2025.
  • The last three reported values for Divestments were $1.4 million (Q3 2025), $1.2 million (Q1 2025), and $1.4 million (Q3 2024) per Business Quant data.